Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

Investing.com - TD Cowen维持了对CVS Health (NYSE: CVS )的买入评级和95.00美元的目标价，表示该公司可能从Centene (NYSE: CNC )面临的挑战中受益。根据 InvestingPro 数据，Centene目前的市盈率为5.23，分析师目标价在45美元至92美元之间，反映了市场在当前挑战下的复杂情绪。

CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it ...

芝加哥 - 年收入超过376亿美元、根据 InvestingPro 分析目前被低估的医疗保健巨头CVS Health (NYSE: CVS )周四在芝加哥浸信会学院开设了一个新的劳动力创新和人才中心 (WITC)，旨在为社区成员提供就业培训。

CVS Health Corporation (NYSE:CVS) is one of the Best Dividend Stocks of 2025. Following a challenging year in 2024, CVS ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

Shares of CVS Health Corp. slipped 4.28% to $66.60 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.47% to 6,227.42 and the Dow ...

Shares of CVS Health are trading higher Thursday afternoon. The stock is climbing after a GOP healthcare bill hit a roadblock ...

In the assessment of 12-month price targets, analysts unveil insights for CVS Health, presenting an average target of $79.0, ...